 |
Diabetes
Briefing 12/08 |
| |
New Diabetes Briefing is now available (NHS,
UK) |
| |
|
|
44th
EASD Annual Meeting Rome, Italy |
| |
Provisional Programme (EASD) |
| |
|
|
American
Diabetes Association Applauds U.S. Congress for Extending Special
Diabetes Programs |
| |
The American Diabetes Association (ADA) applauds
the U.S. Congress for voting in favor of extending the Special
Diabetes Programs (SDP) for two more years (American Diabetes Association) |
| |
|
|
New
therapeutic approaches to diabetic gastroparesis. |
| |
Intrapyloric injection of botulinum toxin is
effective in improving the complex symptoms and clinical syndrome
associated with diabetic gastroparesis resistant to conventional
treatmen (PubMed, USA) |
| |
|
|
The
quality of life and economic burden of neuropathy in diabetic
patients in Germany in 2002-Results from the diabetic microvascular
complications (DIMICO) study |
| |
The results described in this report show that
diabetic neuropathy in adults with type 1 or type 2 diabetes generates
significant reductions in the patient's quality of life and a substantial
economic burden both for society and health insurance. (PubMed,
USA) |
| |
|
|
The
pathogenesis of diabetic nephropathy |
| |
We touch on the expanding clinical data regarding
markers of nephropathy, such as microalbuminuria, and put them
into context; microalbuminuria reflects cardiovascular and not
renal risk (PubMed, USA) |
| |
|
|
Design
of a nurse-run, telephone-based intervention to improve lipids
in diabetics. |
| |
This randomized, controlled trial tested the
effectiveness of a nurse-run, telephone-based intervention to improve
lipid control in patients with diabetes (PubMed, USA) |
| |
|
|
Effects
of dietary catechins on glucose tolerance, blood pressure and
oxidative status in Goto-Kakizaki rats. |
| |
From these results it is concluded that dietary
catechins may be effective in delaying the progression of diabetes
and the associated oxidative stress (PubMed, USA) |
| |
|
|
Introducing
GOAT: a target for obesity and anti-diabetic drugs? |
| |
Here, we review what is currently known about
the regulatory role of ghrelin O-acyltransferase (GOAT) and discuss
the potential of this novel approach for treating obesity and type-2
diabetes (PubMed, USA) |
| |
|
|
Type
2 diabetes mellitus: clinical and aetiologic types, therapy and
quality of glycaemic control of ambulatory patients. |
| |
Type 2 diabetes is a heterogeneous disease where
clinical judgement alone does not adequately tell the various aetiological
types apart without additional laboratory testing of C-peptide
levels and GAD antibody status. This may partly explain the inappropriate
treatment choices for the various aetiological types with consequent
sub-optimal glycaemic control of those patients (PubMed, USA) |
| |
|
|
India’s
Public and Private Sectors Should Unite to Address Diabetes Epidemic |
| |
Central and state governments as well as private
industry and universities are among some of the groups that should
unite to enact policy changes addressing India’s growing diabetes epidemic, say leading U.S. and global diabetes researchers
(WebWire) |
| |
|
|
Mixed
results confuse diabetes debate |
| |
Researchers who are comparing two diabetes trials
say they are getting some insight into why patients in one were
more likely to die after aggressive treatment, while patients in
another were not (ABC, Australia) |
| |
|
|
Study
looks into diabetes remedy |
| |
A delivery agent known SNAC, developed by biopharmaceutical
firm Emisphere Technologies, has been incorporated into tablets
of GLP-1 peptide to asses how safely and effectively the treatment
can be delivered (Pharmacy Europe) |
| |
|
